ArticleFrontiers in oncology2021

Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas.

Ricardo Rivera-Soto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.